Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Portsmouth
Observed name:
D. Portsmouth
Institution:
Baxter (Austria)
Observed institution:
Baxter (Austria)
OpenAlex ID:
A5034279361
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial
2013
·
Nina Wressnigg
, Eva-Maria Pöllabauer
, et al.
·
The Lancet Infectious Diseases
·
116
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
2014
·
Annett Hessel
, Helga Savidis-Dacho
, et al.
·
PLoS ONE
·
66
PDF
A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato
2014
·
Nina Wressnigg
, P. Noel Barrett
, et al.
·
Clinical and Vaccine Immunology
·
55
PDF
An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial
2014
·
Nina Wressnigg
, Maikel V. W. van der Velden
, et al.
·
Clinical and Vaccine Immunology
·
51
Tick-borne encephalitis virus vaccines
2013
·
P. Noel Barrett
, Daniel Portsmouth
, et al.
·
Elsevier eBooks
·
47
Developing cell culture-derived pandemic vaccines.
2010
·
P Noel Barrett
, Daniel Portsmouth
, et al.
·
PubMed
·
46
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial
2011
·
Gerald Aichinger
, Hartmut J. Ehrlich
, et al.
·
Vaccine
·
37
Clinical development of a Vero cell culture-derived seasonal influenza vaccine
2011
·
Hartmut J. Ehrlich
, Gregory Berezuk
, et al.
·
Vaccine
·
35
Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
2013
·
M. V. W. van der Velden
, R. Fritz
, et al.
·
The Journal of Infectious Diseases
·
29
A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals
2012
·
H. J. Ehrlich
, J. Singer
, et al.
·
Clinical Infectious Diseases
·
28
Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines
2015
·
Yvonne Beck
, Richard Fritz
, et al.
·
Journal of Virology
·
27
H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
2011
·
M. Keith Howard
, Nicolas Sabarth
, et al.
·
PLoS ONE
·
25
PDF
Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development
2013
·
P Noel Barrett
, Daniel Portsmouth
, et al.
·
Expert Review of Vaccines
·
22
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice
2014
·
Christine Hohenadl
, Walter Wodal
, et al.
·
Virology Journal
·
20
PDF
Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs
2015
·
Walter Wodal
, Michael G. Schwendinger
, et al.
·
PLoS ONE
·
19
PDF
Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model
2013
·
Michael G. Schwendinger
, Maria O'Rourke
, et al.
·
PLoS ONE
·
17
PDF
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine
2012
·
Hartmut J. Ehrlich
, Markus Müller
, et al.
·
Vaccine
·
16
A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies
2013
·
P Noel Barrett
, Daniel Portsmouth
·
Expert Review of Vaccines
·
14
PDF
Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients
2014
·
Maikel V. W. van der Velden
, Alexander Geisberger
, et al.
·
Clinical and Vaccine Immunology
·
13
PDF
Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
2014
·
Gerald Aichinger
, Barbara Grohmann-Izay
, et al.
·
Clinical and Vaccine Immunology
·
11
The need for a new vaccine against lyme borreliosis
2013
·
P Noel Barrett
, Daniel Portsmouth
·
Expert Review of Vaccines
·
10
PDF
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate
2012
·
Walter Wodal
, Falko G. Falkner
, et al.
·
Vaccine
·
10
Avian Suspension Culture Cell Lines for Production of Vaccines and Other Biologicals
2014
·
Manfred Reiter
, Daniel Portsmouth
, et al.
·
Wiley eBooks
·
6
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination
2012
·
Nicolas Sabarth
, Helga Savidis-Dacho
, et al.
·
Vaccine
·
5
Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients
2014
·
Richard Fritz
, Nicole Hetzelt
, et al.
·
Open Forum Infectious Diseases
·
2
PDF
Show more works
View as search
Works count:
29
Citation count:
730
H-index:
16
I10-index:
22
Year
Topic
Type